Ovarian endometrioma (OEM), a particularly severe form of endometriosis, is an oestrogen-dependent condition often associated with pain and infertility. The mechanisms by which OEM impairs fertility, particularly through its direct …
Orexo converts vipoglanstat royalties into Gesynta stake The Pharma Letter
Lab tech firm BioGrad opening £25m women's health centre Business Live
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma
Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …
Heterotaxia is characterized by an abnormal positioning of the thoracic and/or abdominal organs, resulting in various physiological and hemodynamic implications. Congenital heart disease involves structural irregularities in the heart or …
The dynamic nature of human endometrial tissue presents unique challenges in analysis. Despite extensive research into endometrial disorders such as endometriosis and infertility, recent systematic reviews have highlighted concerning issues …
What is the hormone receptor profile of adenomyosis lesions in comparison to correctly located endometrium?